Global Migraine Drugs Market Growth 2023-2028

Report ID: 1172091 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Migraine Drugs Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Migraine Drugs by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Migraine Drugs by Country/Region, 2017, 2022 & 2028
    2.2 Migraine Drugs Segment by Type
        2.2.1 Sumatriptan
        2.2.2 Zolmitriptan
        2.2.3 Rizatriptan
        2.2.4 Others Drug
    2.3 Migraine Drugs Sales by Type
        2.3.1 Global Migraine Drugs Sales Market Share by Type (2017-2022)
        2.3.2 Global Migraine Drugs Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Migraine Drugs Sale Price by Type (2017-2022)
    2.4 Migraine Drugs Segment by Application
        2.4.1 Hospitals
        2.4.2 Clinics
        2.4.3 Household Use
        2.4.4 Others
    2.5 Migraine Drugs Sales by Application
        2.5.1 Global Migraine Drugs Sale Market Share by Application (2017-2022)
        2.5.2 Global Migraine Drugs Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Migraine Drugs Sale Price by Application (2017-2022)
3 Global Migraine Drugs by Company
    3.1 Global Migraine Drugs Breakdown Data by Company
        3.1.1 Global Migraine Drugs Annual Sales by Company (2020-2022)
        3.1.2 Global Migraine Drugs Sales Market Share by Company (2020-2022)
    3.2 Global Migraine Drugs Annual Revenue by Company (2020-2022)
        3.2.1 Global Migraine Drugs Revenue by Company (2020-2022)
        3.2.2 Global Migraine Drugs Revenue Market Share by Company (2020-2022)
    3.3 Global Migraine Drugs Sale Price by Company
    3.4 Key Manufacturers Migraine Drugs Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Migraine Drugs Product Location Distribution
        3.4.2 Players Migraine Drugs Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Migraine Drugs by Geographic Region
    4.1 World Historic Migraine Drugs Market Size by Geographic Region (2017-2022)
        4.1.1 Global Migraine Drugs Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Migraine Drugs Annual Revenue by Geographic Region
    4.2 World Historic Migraine Drugs Market Size by Country/Region (2017-2022)
        4.2.1 Global Migraine Drugs Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Migraine Drugs Annual Revenue by Country/Region
    4.3 Americas Migraine Drugs Sales Growth
    4.4 APAC Migraine Drugs Sales Growth
    4.5 Europe Migraine Drugs Sales Growth
    4.6 Middle East & Africa Migraine Drugs Sales Growth
5 Americas
    5.1 Americas Migraine Drugs Sales by Country
        5.1.1 Americas Migraine Drugs Sales by Country (2017-2022)
        5.1.2 Americas Migraine Drugs Revenue by Country (2017-2022)
    5.2 Americas Migraine Drugs Sales by Type
    5.3 Americas Migraine Drugs Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Migraine Drugs Sales by Region
        6.1.1 APAC Migraine Drugs Sales by Region (2017-2022)
        6.1.2 APAC Migraine Drugs Revenue by Region (2017-2022)
    6.2 APAC Migraine Drugs Sales by Type
    6.3 APAC Migraine Drugs Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Migraine Drugs by Country
        7.1.1 Europe Migraine Drugs Sales by Country (2017-2022)
        7.1.2 Europe Migraine Drugs Revenue by Country (2017-2022)
    7.2 Europe Migraine Drugs Sales by Type
    7.3 Europe Migraine Drugs Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Migraine Drugs by Country
        8.1.1 Middle East & Africa Migraine Drugs Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Migraine Drugs Revenue by Country (2017-2022)
    8.2 Middle East & Africa Migraine Drugs Sales by Type
    8.3 Middle East & Africa Migraine Drugs Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Migraine Drugs
    10.3 Manufacturing Process Analysis of Migraine Drugs
    10.4 Industry Chain Structure of Migraine Drugs
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Migraine Drugs Distributors
    11.3 Migraine Drugs Customer
12 World Forecast Review for Migraine Drugs by Geographic Region
    12.1 Global Migraine Drugs Market Size Forecast by Region
        12.1.1 Global Migraine Drugs Forecast by Region (2023-2028)
        12.1.2 Global Migraine Drugs Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Migraine Drugs Forecast by Type
    12.7 Global Migraine Drugs Forecast by Application
13 Key Players Analysis
    13.1 Allergan
        13.1.1 Allergan Company Information
        13.1.2 Allergan Migraine Drugs Product Offered
        13.1.3 Allergan Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Allergan Main Business Overview
        13.1.5 Allergan Latest Developments
    13.2 Merck
        13.2.1 Merck Company Information
        13.2.2 Merck Migraine Drugs Product Offered
        13.2.3 Merck Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Merck Main Business Overview
        13.2.5 Merck Latest Developments
    13.3 Pfizer
        13.3.1 Pfizer Company Information
        13.3.2 Pfizer Migraine Drugs Product Offered
        13.3.3 Pfizer Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Pfizer Main Business Overview
        13.3.5 Pfizer Latest Developments
    13.4 Teva
        13.4.1 Teva Company Information
        13.4.2 Teva Migraine Drugs Product Offered
        13.4.3 Teva Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Teva Main Business Overview
        13.4.5 Teva Latest Developments
    13.5 Pfizer
        13.5.1 Pfizer Company Information
        13.5.2 Pfizer Migraine Drugs Product Offered
        13.5.3 Pfizer Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Pfizer Main Business Overview
        13.5.5 Pfizer Latest Developments
    13.6 Johnson & Johnson
        13.6.1 Johnson & Johnson Company Information
        13.6.2 Johnson & Johnson Migraine Drugs Product Offered
        13.6.3 Johnson & Johnson Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Johnson & Johnson Main Business Overview
        13.6.5 Johnson & Johnson Latest Developments
    13.7 Endo International
        13.7.1 Endo International Company Information
        13.7.2 Endo International Migraine Drugs Product Offered
        13.7.3 Endo International Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Endo International Main Business Overview
        13.7.5 Endo International Latest Developments
    13.8 GlaxoSmithKline
        13.8.1 GlaxoSmithKline Company Information
        13.8.2 GlaxoSmithKline Migraine Drugs Product Offered
        13.8.3 GlaxoSmithKline Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 GlaxoSmithKline Main Business Overview
        13.8.5 GlaxoSmithKline Latest Developments
    13.9 Impax
        13.9.1 Impax Company Information
        13.9.2 Impax Migraine Drugs Product Offered
        13.9.3 Impax Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Impax Main Business Overview
        13.9.5 Impax Latest Developments
    13.10 Abbott
        13.10.1 Abbott Company Information
        13.10.2 Abbott Migraine Drugs Product Offered
        13.10.3 Abbott Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Abbott Main Business Overview
        13.10.5 Abbott Latest Developments
    13.11 Bayer
        13.11.1 Bayer Company Information
        13.11.2 Bayer Migraine Drugs Product Offered
        13.11.3 Bayer Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Bayer Main Business Overview
        13.11.5 Bayer Latest Developments
    13.12 Eli Lilly
        13.12.1 Eli Lilly Company Information
        13.12.2 Eli Lilly Migraine Drugs Product Offered
        13.12.3 Eli Lilly Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Eli Lilly Main Business Overview
        13.12.5 Eli Lilly Latest Developments
    13.13 Ethypharm
        13.13.1 Ethypharm Company Information
        13.13.2 Ethypharm Migraine Drugs Product Offered
        13.13.3 Ethypharm Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Ethypharm Main Business Overview
        13.13.5 Ethypharm Latest Developments
    13.14 Kowa Pharmaceuticals America
        13.14.1 Kowa Pharmaceuticals America Company Information
        13.14.2 Kowa Pharmaceuticals America Migraine Drugs Product Offered
        13.14.3 Kowa Pharmaceuticals America Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.14.4 Kowa Pharmaceuticals America Main Business Overview
        13.14.5 Kowa Pharmaceuticals America Latest Developments
    13.15 Winston Pharmaceuticals
        13.15.1 Winston Pharmaceuticals Company Information
        13.15.2 Winston Pharmaceuticals Migraine Drugs Product Offered
        13.15.3 Winston Pharmaceuticals Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.15.4 Winston Pharmaceuticals Main Business Overview
        13.15.5 Winston Pharmaceuticals Latest Developments
    13.16 AstraZeneca
        13.16.1 AstraZeneca Company Information
        13.16.2 AstraZeneca Migraine Drugs Product Offered
        13.16.3 AstraZeneca Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.16.4 AstraZeneca Main Business Overview
        13.16.5 AstraZeneca Latest Developments
14 Research Findings and Conclusion
List of Tables
    Table 1. Migraine Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Migraine Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Sumatriptan
    Table 4. Major Players of Zolmitriptan
    Table 5. Major Players of Rizatriptan
    Table 6. Major Players of Others Drug
    Table 7. Global Migraine Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 8. Global Migraine Drugs Sales Market Share by Type (2017-2022)
    Table 9. Global Migraine Drugs Revenue by Type (2017-2022) & ($ million)
    Table 10. Global Migraine Drugs Revenue Market Share by Type (2017-2022)
    Table 11. Global Migraine Drugs Sale Price by Type (2017-2022) & (USD/Pcs)
    Table 12. Global Migraine Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 13. Global Migraine Drugs Sales Market Share by Application (2017-2022)
    Table 14. Global Migraine Drugs Revenue by Application (2017-2022)
    Table 15. Global Migraine Drugs Revenue Market Share by Application (2017-2022)
    Table 16. Global Migraine Drugs Sale Price by Application (2017-2022) & (USD/Pcs)
    Table 17. Global Migraine Drugs Sales by Company (2020-2022) & (K Pcs)
    Table 18. Global Migraine Drugs Sales Market Share by Company (2020-2022)
    Table 19. Global Migraine Drugs Revenue by Company (2020-2022) ($ Millions)
    Table 20. Global Migraine Drugs Revenue Market Share by Company (2020-2022)
    Table 21. Global Migraine Drugs Sale Price by Company (2020-2022) & (USD/Pcs)
    Table 22. Key Manufacturers Migraine Drugs Producing Area Distribution and Sales Area
    Table 23. Players Migraine Drugs Products Offered
    Table 24. Migraine Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 25. New Products and Potential Entrants
    Table 26. Mergers & Acquisitions, Expansion
    Table 27. Global Migraine Drugs Sales by Geographic Region (2017-2022) & (K Pcs)
    Table 28. Global Migraine Drugs Sales Market Share Geographic Region (2017-2022)
    Table 29. Global Migraine Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 30. Global Migraine Drugs Revenue Market Share by Geographic Region (2017-2022)
    Table 31. Global Migraine Drugs Sales by Country/Region (2017-2022) & (K Pcs)
    Table 32. Global Migraine Drugs Sales Market Share by Country/Region (2017-2022)
    Table 33. Global Migraine Drugs Revenue by Country/Region (2017-2022) & ($ millions)
    Table 34. Global Migraine Drugs Revenue Market Share by Country/Region (2017-2022)
    Table 35. Americas Migraine Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 36. Americas Migraine Drugs Sales Market Share by Country (2017-2022)
    Table 37. Americas Migraine Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 38. Americas Migraine Drugs Revenue Market Share by Country (2017-2022)
    Table 39. Americas Migraine Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 40. Americas Migraine Drugs Sales Market Share by Type (2017-2022)
    Table 41. Americas Migraine Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 42. Americas Migraine Drugs Sales Market Share by Application (2017-2022)
    Table 43. APAC Migraine Drugs Sales by Region (2017-2022) & (K Pcs)
    Table 44. APAC Migraine Drugs Sales Market Share by Region (2017-2022)
    Table 45. APAC Migraine Drugs Revenue by Region (2017-2022) & ($ Millions)
    Table 46. APAC Migraine Drugs Revenue Market Share by Region (2017-2022)
    Table 47. APAC Migraine Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 48. APAC Migraine Drugs Sales Market Share by Type (2017-2022)
    Table 49. APAC Migraine Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 50. APAC Migraine Drugs Sales Market Share by Application (2017-2022)
    Table 51. Europe Migraine Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 52. Europe Migraine Drugs Sales Market Share by Country (2017-2022)
    Table 53. Europe Migraine Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 54. Europe Migraine Drugs Revenue Market Share by Country (2017-2022)
    Table 55. Europe Migraine Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 56. Europe Migraine Drugs Sales Market Share by Type (2017-2022)
    Table 57. Europe Migraine Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 58. Europe Migraine Drugs Sales Market Share by Application (2017-2022)
    Table 59. Middle East & Africa Migraine Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 60. Middle East & Africa Migraine Drugs Sales Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Migraine Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 62. Middle East & Africa Migraine Drugs Revenue Market Share by Country (2017-2022)
    Table 63. Middle East & Africa Migraine Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 64. Middle East & Africa Migraine Drugs Sales Market Share by Type (2017-2022)
    Table 65. Middle East & Africa Migraine Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 66. Middle East & Africa Migraine Drugs Sales Market Share by Application (2017-2022)
    Table 67. Key Market Drivers & Growth Opportunities of Migraine Drugs
    Table 68. Key Market Challenges & Risks of Migraine Drugs
    Table 69. Key Industry Trends of Migraine Drugs
    Table 70. Migraine Drugs Raw Material
    Table 71. Key Suppliers of Raw Materials
    Table 72. Migraine Drugs Distributors List
    Table 73. Migraine Drugs Customer List
    Table 74. Global Migraine Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 75. Global Migraine Drugs Sales Market Forecast by Region
    Table 76. Global Migraine Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 77. Global Migraine Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 78. Americas Migraine Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 79. Americas Migraine Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 80. APAC Migraine Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 81. APAC Migraine Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 82. Europe Migraine Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 83. Europe Migraine Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Middle East & Africa Migraine Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 85. Middle East & Africa Migraine Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 86. Global Migraine Drugs Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 87. Global Migraine Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 88. Global Migraine Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 89. Global Migraine Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 90. Global Migraine Drugs Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 91. Global Migraine Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 92. Global Migraine Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 93. Global Migraine Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 94. Allergan Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 95. Allergan Migraine Drugs Product Offered
    Table 96. Allergan Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 97. Allergan Main Business
    Table 98. Allergan Latest Developments
    Table 99. Merck Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 100. Merck Migraine Drugs Product Offered
    Table 101. Merck Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 102. Merck Main Business
    Table 103. Merck Latest Developments
    Table 104. Pfizer Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 105. Pfizer Migraine Drugs Product Offered
    Table 106. Pfizer Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 107. Pfizer Main Business
    Table 108. Pfizer Latest Developments
    Table 109. Teva Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 110. Teva Migraine Drugs Product Offered
    Table 111. Teva Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 112. Teva Main Business
    Table 113. Teva Latest Developments
    Table 114. Pfizer Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 115. Pfizer Migraine Drugs Product Offered
    Table 116. Pfizer Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 117. Pfizer Main Business
    Table 118. Pfizer Latest Developments
    Table 119. Johnson & Johnson Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 120. Johnson & Johnson Migraine Drugs Product Offered
    Table 121. Johnson & Johnson Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 122. Johnson & Johnson Main Business
    Table 123. Johnson & Johnson Latest Developments
    Table 124. Endo International Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 125. Endo International Migraine Drugs Product Offered
    Table 126. Endo International Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 127. Endo International Main Business
    Table 128. Endo International Latest Developments
    Table 129. GlaxoSmithKline Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 130. GlaxoSmithKline Migraine Drugs Product Offered
    Table 131. GlaxoSmithKline Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 132. GlaxoSmithKline Main Business
    Table 133. GlaxoSmithKline Latest Developments
    Table 134. Impax Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 135. Impax Migraine Drugs Product Offered
    Table 136. Impax Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 137. Impax Main Business
    Table 138. Impax Latest Developments
    Table 139. Abbott Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 140. Abbott Migraine Drugs Product Offered
    Table 141. Abbott Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 142. Abbott Main Business
    Table 143. Abbott Latest Developments
    Table 144. Bayer Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 145. Bayer Migraine Drugs Product Offered
    Table 146. Bayer Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 147. Bayer Main Business
    Table 148. Bayer Latest Developments
    Table 149. Eli Lilly Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 150. Eli Lilly Migraine Drugs Product Offered
    Table 151. Eli Lilly Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 152. Eli Lilly Main Business
    Table 153. Eli Lilly Latest Developments
    Table 154. Ethypharm Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 155. Ethypharm Migraine Drugs Product Offered
    Table 156. Ethypharm Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 157. Ethypharm Main Business
    Table 158. Ethypharm Latest Developments
    Table 159. Kowa Pharmaceuticals America Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 160. Kowa Pharmaceuticals America Migraine Drugs Product Offered
    Table 161. Kowa Pharmaceuticals America Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 162. Kowa Pharmaceuticals America Main Business
    Table 163. Kowa Pharmaceuticals America Latest Developments
    Table 164. Winston Pharmaceuticals Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 165. Winston Pharmaceuticals Migraine Drugs Product Offered
    Table 166. Winston Pharmaceuticals Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 167. Winston Pharmaceuticals Main Business
    Table 168. Winston Pharmaceuticals Latest Developments
    Table 169. AstraZeneca Basic Information, Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 170. AstraZeneca Migraine Drugs Product Offered
    Table 171. AstraZeneca Migraine Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 172. AstraZeneca Main Business
    Table 173. AstraZeneca Latest Developments
List of Figures
    Figure 1. Picture of Migraine Drugs
    Figure 2. Migraine Drugs Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Migraine Drugs Sales Growth Rate 2017-2028 (K Pcs)
    Figure 7. Global Migraine Drugs Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Migraine Drugs Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Sumatriptan
    Figure 10. Product Picture of Zolmitriptan
    Figure 11. Product Picture of Rizatriptan
    Figure 12. Product Picture of Others Drug
    Figure 13. Global Migraine Drugs Sales Market Share by Type in 2021
    Figure 14. Global Migraine Drugs Revenue Market Share by Type (2017-2022)
    Figure 15. Migraine Drugs Consumed in Hospitals
    Figure 16. Global Migraine Drugs Market: Hospitals (2017-2022) & (K Pcs)
    Figure 17. Migraine Drugs Consumed in Clinics
    Figure 18. Global Migraine Drugs Market: Clinics (2017-2022) & (K Pcs)
    Figure 19. Migraine Drugs Consumed in Household Use
    Figure 20. Global Migraine Drugs Market: Household Use (2017-2022) & (K Pcs)
    Figure 21. Migraine Drugs Consumed in Others
    Figure 22. Global Migraine Drugs Market: Others (2017-2022) & (K Pcs)
    Figure 23. Global Migraine Drugs Sales Market Share by Application (2017-2022)
    Figure 24. Global Migraine Drugs Revenue Market Share by Application in 2021
    Figure 25. Migraine Drugs Revenue Market by Company in 2021 ($ Million)
    Figure 26. Global Migraine Drugs Revenue Market Share by Company in 2021
    Figure 27. Global Migraine Drugs Sales Market Share by Geographic Region (2017-2022)
    Figure 28. Global Migraine Drugs Revenue Market Share by Geographic Region in 2021
    Figure 29. Global Migraine Drugs Sales Market Share by Region (2017-2022)
    Figure 30. Global Migraine Drugs Revenue Market Share by Country/Region in 2021
    Figure 31. Americas Migraine Drugs Sales 2017-2022 (K Pcs)
    Figure 32. Americas Migraine Drugs Revenue 2017-2022 ($ Millions)
    Figure 33. APAC Migraine Drugs Sales 2017-2022 (K Pcs)
    Figure 34. APAC Migraine Drugs Revenue 2017-2022 ($ Millions)
    Figure 35. Europe Migraine Drugs Sales 2017-2022 (K Pcs)
    Figure 36. Europe Migraine Drugs Revenue 2017-2022 ($ Millions)
    Figure 37. Middle East & Africa Migraine Drugs Sales 2017-2022 (K Pcs)
    Figure 38. Middle East & Africa Migraine Drugs Revenue 2017-2022 ($ Millions)
    Figure 39. Americas Migraine Drugs Sales Market Share by Country in 2021
    Figure 40. Americas Migraine Drugs Revenue Market Share by Country in 2021
    Figure 41. United States Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Canada Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 43. Mexico Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Brazil Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 45. APAC Migraine Drugs Sales Market Share by Region in 2021
    Figure 46. APAC Migraine Drugs Revenue Market Share by Regions in 2021
    Figure 47. China Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Japan Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 49. South Korea Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 50. Southeast Asia Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 51. India Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Australia Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Europe Migraine Drugs Sales Market Share by Country in 2021
    Figure 54. Europe Migraine Drugs Revenue Market Share by Country in 2021
    Figure 55. Germany Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 56. France Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 57. UK Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Italy Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Russia Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Middle East & Africa Migraine Drugs Sales Market Share by Country in 2021
    Figure 61. Middle East & Africa Migraine Drugs Revenue Market Share by Country in 2021
    Figure 62. Egypt Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 63. South Africa Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Israel Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 65. Turkey Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 66. GCC Country Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 67. Manufacturing Cost Structure Analysis of Migraine Drugs in 2021
    Figure 68. Manufacturing Process Analysis of Migraine Drugs
    Figure 69. Industry Chain Structure of Migraine Drugs
    Figure 70. Channels of Distribution
    Figure 71. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Migraine Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Migraine Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Migraine Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports